Management of Hypertensive Nephrosclerosis with Proteinuria

Diagnosis and Differential Diagnosis

• The American Journal of Kidney Diseases suggests that diabetic kidney disease must be evaluated given the association between hypertension and diabetes, and to look for diabetic retinopathy which has 84-100% sensitivity for diabetic glomerulopathy 3
• The American Journal of Kidney Diseases recommends considering chronic glomerulonephritis (IgA nephropathy, focal segmental glomerulosclerosis, membranous nephropathy) if active urinary sediment, rapidly declining kidney function, or systemic symptoms are present 3
• The American Journal of Kidney Diseases advises to consider renal artery stenosis, particularly if refractory hypertension or significant decrease in kidney function after RAS blockade occurs 3

Diagnostic Workup

• The European Heart Journal recommends calculating serum creatinine and eGFR using the CKD-EPI formula to stage chronic kidney disease 4, 1
• The European Heart Journal and Praxis Medical Insights suggest quantifying proteinuria with 24-hour urine collection or spot urine protein-to-creatinine ratio to establish a baseline 4, 5
• The American Journal of Kidney Diseases recommends complete urinalysis with microscopy to look for active sediment (RBC casts, dysmorphic RBCs) suggesting glomerulonephritis versus bland sediment typical of hypertensive nephrosclerosis 3

Management

• The American College of Cardiology and Praxis Medical Insights recommend initiating ACE inhibitor (preferred) or ARB at maximum tolerated doses, targeting blood pressure <130/80 mmHg, as this patient has hypertensive nephrosclerosis with significant proteinuria requiring urgent renoprotective therapy 1, 2
• The European Heart Journal suggests expecting and tolerating up to 20-30% increase in serum creatinine after initiation of ACE inhibitor/ARB, which reflects hemodynamic changes from reduced intraglomerular pressure, not progressive kidney damage 4, 1
• The American College of Cardiology and Praxis Medical Insights advise to add a thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide) if BP remains ≥140/90 mmHg on ACE inhibitor/ARB alone 1, 2

Monitoring

• The American Journal of Kidney Diseases recommends rechecking serum creatinine and potassium within 7-14 days after initiating or uptitrating ACE inhibitor/ARB 1, 2
• The Journal of the American Society of Nephrology suggests assessing treatment response by monitoring proteinuria reduction (goal: reduce by ≥30-50% from baseline) 6, 5
• The European Heart Journal advises to monitor blood pressure at every visit until controlled, then periodically 2

Lifestyle Modifications

• The American College of Cardiology and Praxis Medical Insights recommend dietary sodium restriction to <2 g/day (ideally 1,200-2,300 mg/day) to enhance antihypertensive medication effectiveness and reduce proteinuria 1, 2
• The American College of Cardiology and Praxis Medical Insights suggest weight loss if BMI >25 through caloric restriction 1
• The American College of Cardiology and Praxis Medical Insights advise aerobic exercise ≥150 minutes/week of moderate-intensity activity 1, 2